Status:
NOT_YET_RECRUITING
Optimizing Linezolid Dosing in Patients With Advanced Renal Impairment: a Therapeutic Drug Monitoring-based Evaluation
Lead Sponsor:
Alexandria University
Conditions:
Kidney Disease
Eligibility:
All Genders
18-90 years
Phase:
PHASE4
Brief Summary
The goal of this clinical trial is to adjust the Linezolid dose according to its blood level in adults with kidney diseases. It will also learn about the safety of linezolid. The main questions it aim...
Detailed Description
Linezolid is a crucial antibiotic prescribed for the treatment of various infectious diseases such as pneumonia, skin infections, and catheter-related bloodstream infections. Linezolid covers gram-pos...
Eligibility Criteria
Inclusion
- Advanced renal impairment, Hemodialysis patients
Exclusion
- Pregnancy, Lactating females, Advanced Liver impairment, Cases using antidepressants or antipsychotics, Cases suffering from Hematological blood diseases, and/or chronic Immune thrombocytopenia.
Key Trial Info
Start Date :
October 15 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 15 2026
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT07138521
Start Date
October 15 2025
End Date
May 15 2026
Last Update
August 24 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.